ARTV (STOCKS)
Artiva Biotherapeutics, Inc. Common Stock
$11.200000
-0.330000 (-2.86%)
Prev close: $11.530000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Fred Aslan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $590.42M
- Employees
- 105
- P/E (TTM)
- -3.48
- P/B (TTM)
- 1.62
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $5.33M |
| Operating Expenses | $96.15M |
| Research and Development | $75.86M |
| Other Operating Expenses | $20.29M |
| Operating Income/Loss | -$96.15M |
| Income/Loss From Continuing Operations After Tax | -$90.82M |
| Income/Loss From Continuing Operations Before Tax | -$90.82M |
| Net Income/Loss | -$90.82M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$90.82M |
| Net Income/Loss Available To Common Stockholders, Basic | -$90.82M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.23 |
| Diluted Earnings Per Share | -$3.23 |
| Basic Average Shares | 56,610,958 |
| Diluted Average Shares | 56,610,958 |
| Assets | $368.63M |
| Current Assets | $352.28M |
| Cash | $349.40M |
| Other Current Assets | $2.88M |
| Noncurrent Assets | $16.36M |
| Fixed Assets | $5.67M |
| Other Non-current Assets | $10.69M |
| Liabilities | $21.13M |
| Current Liabilities | $14.58M |
| Accounts Payable | $1.39M |
| Wages | $4.64M |
| Other Current Liabilities | $8.55M |
| Noncurrent Liabilities | $6.55M |
| Equity | $347.50M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $347.50M |
| Liabilities And Equity | $368.63M |
| Net Cash Flow From Operating Activities | -$75.23M |
| Net Cash Flow From Operating Activities, Continuing | -$75.23M |
| Net Cash Flow From Investing Activities | $65.22M |
| Net Cash Flow From Investing Activities, Continuing | $65.22M |
| Net Cash Flow From Financing Activities | $283.00M |
| Net Cash Flow From Financing Activities, Continuing | $283.00M |
| Net Cash Flow | $272.99M |
| Net Cash Flow, Continuing | $272.99M |
| Comprehensive Income/Loss | -$90.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$90.84M |
| Other Comprehensive Income/Loss | -$67.21M |